Keros Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $3,042 | $388 | $37 | $83 |
Gross Profit | 3,042 | 388 | -269 | -194 |
EBITDA | -29,142 | -58,657 | -50,133 | -48,206 |
EBIT | -29,474 | -50,439 | -48,483 | |
Net Income | -46,026 | -52,956 | -45,257 | -43,114 |
Net Change In Cash | 3,042 | 388 | 37 | 83 |
Free Cash Flow | -46,297 | -30,886 | -40,111 | -45,506 |
Cash | 559,931 | 530,684 | 405,863 | 442,443 |
Basic Shares | 40,337 | 36,103 | 36,103 | 29,447 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,550 | $151 | $20,000 | $20,100 |
Gross Profit | 3,550 | -664 | -1,615 | 19,202 |
EBITDA | -185,824 | -152,177 | -103,063 | -56,373 |
EBIT | -187,053 | -152,992 | -104,678 | -57,271 |
Net Income | -187,353 | -152,992 | -104,680 | -58,744 |
Net Change In Cash | 3,550 | 151 | 20,000 | 20,100 |
Cost of Revenue | 49,006 | -34,622 | ||
Free Cash Flow | -162,800 | -126,972 | -71,303 | -63,172 |
Cash | 559,931 | 331,147 | 279,048 | 230,042 |
Basic Shares | 37,437 | 29,447 | 25,241 | 23,333 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.14 |
2024-09-30 | -$1.41 |
2024-06-30 | -$1.25 |
2024-03-31 | -$1.21 |
